International Journal of Infection

Published by: Kowsar

Ebola Hemorrhagic Fever

Maryam Keshtkar Jahromi 1 and Batool Sharifi Mood 2 , *
Authors Information
1 Department of Infectious Diseases, Pennsylvania State University, Hershey, Pennsylvania, USA
2 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: January 01, 2015, 2 (1); e22401
  • Published Online: January 12, 2015
  • Article Type: Review Article
  • Received: July 29, 2014
  • Revised: August 7, 2014
  • Accepted: August 7, 2014
  • DOI: 10.17795/iji-22401

To Cite: Keshtkar Jahromi M, Sharifi Mood B. Ebola Hemorrhagic Fever, Int J Infect. 2015 ; 2(1):e22401. doi: 10.17795/iji-22401.

Abstract
Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. World Health Organization . Ebola virus disease Fact sheet N°103. 2014;
  • 2. Reynard O, Volchkov V, Peyrefitte C. [A first outbreak of Ebola virus in West Africa]. Med Sci (Paris). 2014; 30(6-7): 671-3[DOI][PubMed]
  • 3. Dixon MG, Schafer IJ, Centers for Disease C. Ebola viral disease outbreak--West Africa, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63(25): 548-51[PubMed]
  • 4. Ebola virus.
  • 5. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005; 438(7068): 575-6[DOI][PubMed]
  • 6. Center for Disease Control . Special Pathogens Branch. Questions and Answers about Ebola Hemorrhagic Fever. 2014;
  • 7. Eichner M, Dowell SF, Firese N. Incubation period of ebola hemorrhagic virus subtype zaire. Osong Public Health Res Perspect. 2011; 2(1): 3-7[DOI][PubMed]
  • 8. Hoenen T, Groseth A, Falzarano D, Feldmann H. Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med. 2006; 12(5): 206-15[DOI][PubMed]
  • 9. Fisher-Hoch SP, Platt GS, Neild GH, Southee T, Baskerville A, Raymond RT, et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis. 1985; 152(5): 887-94[PubMed]
  • 10. Gear JH. Clinical aspects of African viral hemorrhagic fevers. Rev Infect Dis. 1989; 11 Suppl 4-82[PubMed]
  • 11. Jahromi MK. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014; 1(2)
  • 12. Morvan JM, Deubel V, Gounon P, Nakoune E, Barriere P, Murri S, et al. Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic. Microbes Infect. 1999; 1(14): 1193-201[PubMed]
  • 13. Pourrut X, Delicat A, Rollin PE, Ksiazek TG, Gonzalez JP, Leroy EM. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis. 2007; 196 Suppl 2-83[DOI][PubMed]
  • 14. Questions and Answers about Ebola Hemorrhagic Fever. 2009;
  • 15. Fauquet CM. Virus taxonomy classification and nomenclature of viruses; 8th report of the International Committee on Taxonomy of Viruses. 2005; : 648
  • 16. Peterson AT, Bauer JT, Mills JN. Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis. 2004; 10(1): 40-7[DOI][PubMed]
  • 17. Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Delicat A, Yaba P, et al. The natural history of Ebola virus in Africa. Microbes Infect. 2005; 7(7-8): 1005-14[DOI][PubMed]
  • 18. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol. 2010; 155(12): 2083-103[DOI][PubMed]
  • 19. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LE, Ksiazek TG, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. 1996; 2(4): 321-5[DOI][PubMed]
  • 20. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 1995; 346(8991-8992): 1669-71[PubMed]
  • 21. Centers for Disease Control and Prevention . Outbreak of Ebola in Guinea, Liberia, and Sierra Leone. 2014;
  • 22. Jeffs B. A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct. 2006; 36(1): 1-4[DOI][PubMed]
  • 23. Bagcchi S. Ebola haemorrhagic fever in west Africa. Lancet Infect Dis. 2014; 14(5): 375[PubMed]
  • 24. Feldmann H. Ebola - A Growing Threat? N Engl J Med. 2014; [DOI][PubMed]
  • 25. Ebola virus disease. 2014;
  • 26. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis. 2010; 16(7): 1087-92[DOI][PubMed]
  • 27. Jason H, Faith K. . American Ebola patient seems to be improving CDC chief says. 2014;
  • 28. Gear JH, Ryan J, Rossouw E. A consideration of the diagnosis of dangerous infectious fevers in South Africa. S Afr Med J. 1978; 53(7): 235-7[PubMed]
  • 29. Grolla A, Lucht A, Dick D, Strong JE, Feldmann H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot. 2005; 98(3): 205-9[PubMed]
  • 30. Bogomolov BP. Differential diagnosis of infectious diseases with hemorrhagic syndrome. Ter Arkh. 1998; 70(4): 63-8[PubMed]
  • 31. Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002; 40(7): 2323-30[PubMed]
  • 32. Niikura M, Ikegami T, Saijo M, Kurane I, Miranda ME, Morikawa S. Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J Clin Microbiol. 2001; 39(9): 3267-71[PubMed]
  • 33. Gibb TR, Norwood DA, Jr., Woollen N, Henchal EA. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol. 2001; 39(11): 4125-30[DOI][PubMed]
  • 34. Sanchez A, Ksiazek TG, Rollin PE, Miranda ME, Trappier SG, Khan AS, et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 1999; 179 Suppl 1-9[DOI][PubMed]
  • 35. Geisbert TW, Jahrling PB. Differentiation of filoviruses by electron microscopy. Virus Res. 1995; 39(2-3): 129-50[PubMed]
  • 36. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004; 78(8): 4330-41[PubMed]
  • 37. Ksiazek TG, Rollin PE, Jahrling PB, Johnson E, Dalgard DW, Peters CJ. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol. 1992; 30(4): 947-50[PubMed]
  • 38. Nkoghe D, Formenty P, Nnegue S, Mve MT, Hypolite I, Leonard P, et al. [Practical guidelines for the management of Ebola infected patients in the field]. Med Trop (Mars). 2004; 64(2): 199-204[PubMed]
  • 39. Pettitt J, Zeitlin L, Kim do H, Working C, Johnson JC, Bohorov O, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013; 5(199): 199ra113[DOI][PubMed]
  • 40. Gilsdorf A, Morgan D, Leitmeyer K. Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation. BMC Public Health. 2012; 12: 1014[DOI][PubMed]
  • 41. Sharifi-Mood B, Metanat M, Alavi-Naini R. Prevalence of crimean-congo hemorrhagic Fever among high risk human groups. Int J High Risk Behav Addict. 2014; 3(1)[DOI][PubMed]
  • 42. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
  • 43. Tabatabaei SM, Hassanzehi A, Pakzad A, Mohammadi M, Madani M. Factors Influencing Crimean-Congo Hemorrhagic Fever Risk Perceptions in the General Population, Southeast Iran. Int J Infection. 2014; (1)
  • 44. Rakhshani M, Abedi poou F, Noori Jangi M, Khorgami P, Hajalizadeh A. A five-member family with Crimean-Congohemorrhagic fever A case series study. Int J infection. 2014; 1(1)
  • 45. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 46. Raabea VN, Borcherta M. Infection control during filoviral hemorrhagic Fever outbreaks. J Glob Infect Dis. 2012; 4(1): 69-74[DOI][PubMed]
  • 47. Fausther-Bovendo H, Mulangu S, Sullivan NJ. Ebolavirus vaccines for humans and apes. Curr Opin Virol. 2012; 2(3): 324-9[DOI][PubMed]
  • 48. Wang Y, Liu Z, Dai Q. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody. Virus Res. 2014; 189: 254-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments